E2F1: a promising regulator in ovarian carcinoma

Lei Zhan(Anhui Medical University), Bing Wei(Anhui Medical University), Enxue Song(Anhui Medical University), Yu Zhang(Wannan Medical College), Wenyan Wang(Anhui Medical University), Yijun Fan(Anhui Medical University)
Tumor Biology
January 9, 2016
10.1007/s13277-015-4770-7
Cited by 85

Related Papers

Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium
|Stem Cell Research & Therapy|2019|294
MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G
|Cancer Letters|2008|216
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆
|Annals of Oncology|2021|212
FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway
|Genome Medicine|2020|192
Polyamine metabolite spermidine rejuvenates oocyte quality by enhancing mitophagy during female reproductive aging
|Nature Aging|2023|192